1. Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial. Issue 4 (April 2022) Authors: Marks, David I; Kirkwood, Amy A; Rowntree, Clare J; Aguiar, Melanie; Bailey, Katharine E; Beaton, Brendan; Cahalin, Paul; Castleton, Anna Z; Clifton-Hadley, Laura; Copland, Mhairi; Goldstone, Anthony H; Kelly, Richard; Lawrie, Emma; Lee, SooWah; McMillan, Andrew K; McMullin, Mary Frances; Menne, ... Journal: Lancet Issue: Volume 9:Issue 4(2022) Page Start: e262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. (17th December 2018) Authors: Rule, Simon; Cook, Gordon; Russell, Nigel H.; Hunter, Ann; Robinson, Stephen; Morley, Nick; Sureda, Anna; Patrick, Pip; Clifton‐Hadley, Laura; Adedayo, Toyin; Kirkwood, Amy; Peggs, Karl S. Journal: British journal of haematology Issue: Volume 184:Number 6(2019) Page Start: 999 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial. Issue 10 (October 2018) Authors: Anderson, Richard A; Remedios, Rachel; Kirkwood, Amy A; Patrick, Pip; Stevens, Linsey; Clifton-Hadley, Laura; Roberts, Tom; Hatton, Chris; Kalakonda, Nagesh; Milligan, Don W; McKay, Pam; Rowntree, Clare; Scott, Fiona M; Johnson, Peter W M Journal: Lancet oncology Issue: Volume 19:Issue 10(2018) Page Start: 1328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial. Issue 4 (April 2022) Authors: Marks, David I; Clifton-Hadley, Laura; Copland, Mhairi; Hussain, Jiaull; Menne, Tobias F; McMillan, Andrew; Moorman, Anthony V; Morley, Nicholas; Okasha, Dina; Patel, Bela; Patrick, Pip; Potter, Michael N; Rowntree, Clare J; Kirkwood, Amy A; Fielding, Adele K Journal: Lancet Issue: Volume 9:Issue 4(2022) Page Start: e276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia. Issue 7 (3rd July 2018) Authors: Gohil, Satyen Harish; Maciocia, Nicola; Patrick, Pip; Roberts, Thomas; Counsell, Nicholas; Smith, Paul; Clifton-Hadley, Laura; Cwynarski, Kate; Pettitt, Andrew; Nathwani, Amit Chunilal Journal: Leukemia & lymphoma Issue: Volume 59:Issue 7(2018) Page Start: 1730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Treatment of classical Hodgkin lymphoma in young adults aged 18–30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012). (11th November 2019) Authors: Townsend, William; Leong, Sarah; Hoskin, Peter; Diez, Patricia; Patrick, Pip; Linch, David; Wong, Wai‐Lup; Kayani, Irfan; Sanghera, Bal; Lopes, Andre; Daw, Stephen; Collins, Graham; Clifton‐Hadley, Laura; Ardeshna, Kirit Journal: British journal of haematology Issue: Volume 189:Number 1(2020) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗